Shitara K, Hirao M, Iwasa S, Oshima T, et al. Phase 1 Study of the Liposomal Formulation of Eribulin (E7389-LF): Results From the Advanced Gastric Cancer Expansion Cohort. Clin Cancer Res 2023 Feb 2:CCR-22-3027. doi: 10.1158/1078-0432.CCR-22-3027.
PMID: 36730323